Release Therapeutics is pleased to announce our participation in the European Society of Gene and Cell Therapy (ESGCT) Congress that will be held from 22–25 October 2024 in Rome, Italy.
We are especially thrilled to share that our strategic partners at the Paris Brain Institute will be presenting the latest preclinical results with our Myo-P4 device in MLD at the ESGCT Congress. To learn more about our programme and its latest developments, when in Rome(!) make sure to connect with our COO, Julien Grogg, PhD, MBA, or send us a message via our contact form here: https://www.release-tx.com/contact
The Release Tx Team
Kommentare